Danielle A. Becktel

ORCID: 0000-0002-8463-0282
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neurological Disease Mechanisms and Treatments
  • Peroxisome Proliferator-Activated Receptors
  • Neurogenesis and neuroplasticity mechanisms
  • Bone and Dental Protein Studies
  • Calpain Protease Function and Regulation
  • Nerve injury and regeneration
  • Immune Response and Inflammation
  • Acute Ischemic Stroke Management
  • Neurological Disorders and Treatments
  • Metabolomics and Mass Spectrometry Studies
  • Atherosclerosis and Cardiovascular Diseases
  • Immune cells in cancer
  • T-cell and B-cell Immunology
  • Oral microbiology and periodontitis research
  • Bone Metabolism and Diseases

University of Arizona
2018-2024

Stanford University
2021

Southern Arizona VA Health Care System
2021

The goal of this study was to evaluate changes in metabolic homeostasis during the first 12 weeks recovery a distal middle cerebral artery occlusion mouse model stroke. To achieve goal, we compared brain metabolomes ipsilateral and contralateral hemispheres from aged male mice up after stroke that age-matched naïve sham mice. There were 707 biochemicals detected each sample by liquid chromatography-mass spectroscopy (LC-MS). Mitochondrial fatty acid β-oxidation, indicated acyl carnitine...

10.1177/0271678x231157298 article EN cc-by-nc Journal of Cerebral Blood Flow & Metabolism 2023-02-11

<h3>Abstract</h3> Here we used mouse models of heart and brain ischemia to compare the inflammatory response in heart, a protein rich organ, brain, lipid organ. We report that ischemia-induced inflammation resolves between one four weeks compared eight 24 brain. Importantly, discovered second burst occurs following ischemia, which coincided with appearance cholesterol crystals within infarct. This wave shares similar cellular molecular profile atherosclerosis is characterized by high levels...

10.1523/eneuro.0076-18.2018 article EN cc-by eNeuro 2018-09-01

Globally, more than 67 million people are living with the effects of ischemic stroke. Importantly, many stroke survivors develop a chronic inflammatory response that may contribute to cognitive impairment, common and debilitating sequela is insufficiently studied currently untreatable. 2-Hydroxypropyl-β-cyclodextrin (HPβCD) an FDA-approved cyclic oligosaccharide can solubilize entrap lipophilic substances. The goal present study was determine whether repeated administration HPβCD curtails by...

10.1523/jneurosci.0933-21.2021 article EN cc-by-nc-sa Journal of Neuroscience 2021-11-24

Up to 30% of stroke patients experience cognitive decline within one year their stroke. There are currently no FDA-approved drugs that can prevent post-stroke decline, in part due a poor understanding the mechanisms involved. We have previously demonstrated B-lymphocyte response stroke, marked by IgA + cells, cause delayed dysfunction mice and similar adaptive immune occurs brains some human suffer from vascular dementia. The stimuli which trigger activation following target antigens, still...

10.1016/j.bbi.2020.09.014 article EN cc-by Brain Behavior and Immunity 2020-09-19

Following ischemic stroke, the degradation of myelin and other cellular membranes surpasses lipid-processing capabilities resident microglia infiltrating macrophages. This imbalance leads to foam cell formation in infarct areas secondary neurodegeneration, instigating sustained inflammation furthering neurological damage. Given that mitochondria are primary sites fatty acid metabolism, augmenting mitochondrial biogenesis (MB) may enhance lipid processing, curtailing post-stroke chronic...

10.3390/ijms242316632 article EN International Journal of Molecular Sciences 2023-11-23

The aim of this study was to test whether poststroke oral administration a small molecule p75 neurotrophin receptor (p75<sup>NTR</sup>) modulator (LM11A-31) can augment neuronal survival and improve recovery in mouse model stroke. Mice were administered LM11A-31 for up 12 weeks, beginning 1 week after Metabolomic analysis revealed that 2 weeks daily treatment, mice received distinct from vehicle-treated by principal component had higher levels serotonin, acetylcholine, dopamine their...

10.1124/jpet.121.000711 article EN Journal of Pharmacology and Experimental Therapeutics 2021-12-10

Abstract Here we used mouse models of heart and brain ischemia to compare the inflammatory response in heart, a protein rich organ, brain, lipid organ. We report that ischemia-induced inflammation resolves between 1 4 weeks compared 8 24 brain. Importantly, discovered second burst occurs following ischemia, which coincided with appearance cholesterol crystals within infarct. This wave shares similar cellular molecular profile atherosclerosis is characterized by high levels osteopontin (OPN)...

10.1101/264275 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2018-02-16

Following ischemic stroke, the degradation of myelin and other cellular membranes surpasses lipid-processing capabilities resident microglia infiltrating macrophages. This imbalance leads to foam cell formation in infarct areas secondary neurodegeneration, instigating sustained inflammation furthering neurological damage. Given that mitochondria are primary sites fatty acid metabolism, augmenting mitochondrial biogenesis (MB) may enhance lipid processing, curtailing post-stroke chronic...

10.20944/preprints202310.1716.v1 preprint EN 2023-10-26

Abstract The goal of this study was to evaluate changes in metabolic homeostasis during the first 12 weeks recovery a distal middle cerebral artery occlusion mouse model stroke. To achieve goal, we compared brain metabolomes ipsilateral and contralateral hemispheres from aged male mice up after stroke that age-matched naïve sham operated mice. There were 707 biochemicals detected each sample by liquid chromatography-mass spectroscopy (LC-MS). Mitochondrial fatty acid β-oxidation, indicated...

10.1101/2022.03.22.485395 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-03-25

Abstract Globally, more than 67 million people are living with the effects of ischemic stroke. Importantly, many stroke survivors develop a chronic inflammatory response that may contribute to cognitive impairment, common and debilitating sequela is insufficiently studied currently untreatable. 2-hydroxypropyl-β-cyclodextrin (HPβCD) an FDA-approved cyclic oligosaccharide can solubilize entrap lipophilic substances. The goal present study was determine whether repeated administration HPβCD...

10.1101/2021.05.03.442388 preprint EN cc-by-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-05-03

ABSTRACT The aim of this study was to test whether post-stroke oral administration a small molecule p75 neurotrophin receptor (p75 NTR ) modulator (LM11A-31) can augment neuronal survival and improve recovery in mouse model stroke. Mice were administered LM11A-31 for up 12 weeks, beginning 1 week after Metabolomic analysis revealed that 2 weeks daily treatment, mice received distinct from vehicle treated by principal component had higher levels serotonin, acetylcholine, dopamine their...

10.1101/2021.04.30.442181 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2021-04-30
Coming Soon ...